PUMA BIOTECHNOLOGY, INC.

PBYI

PUMA BIOTECHNOLOGY, INC.

PBYI

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-12Shares Purchased (TTM):0Shares Sold (TTM):128,941

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:34,348,203Shares Outstanding:50,845,130Institutional Ownership Pct.:67.55%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets Current
Cash And Cash Equivalents At Carrying Value	37	36	30	54	55	63	69	67	67	77	85	82
Marketable Securities Current	57	65	68	41	41	30	32	29	30	30	11	3
Accounts Receivable Net Current	34	26	54	34	26	25	32	55	28	25	48	29
Inventory Net	13	9	6	9	9	9	9	3	9	7	7	6
Prepaid Expense Current	4	3	4	4	4	5	6	3	3	4	4	4
Restricted Cash Current	0	2	2	2	2	-	0	-	-	-	-	-
Other Assets Current	0	0	0	0	0	0	0	0	0	0	1	2
Assets Current	145	142	163	144	137	133	148	157	138	143	156	125
Operating Lease Right Of Use Asset	4	5	5	6	3	4	5	5	6	7	8	9
Property Plant And Equipment Net	0	0	0	0	0	0	1	1	1	1	1	1
Intangible Assets Net Including Goodwill	37	39	41	44	46	49	51	54	56	58	61	63
Restricted Cash Noncurrent	-	-	0	0	0	2	2	2	2	2	2	3
Deferred Income Tax Assets Net	4	4	4	7	7	7	7	-	-	-	0	-
Prepaid Expense And Other Assets Noncurrent	3	3	3	2	2	2	0	2	2	3	3	3
Assets	193	193	216	203	195	196	213	221	205	214	231	204
Liabilities Current
Accounts Payable Current	3	8	5	6	5	6	6	8	14	9	7	5
Accrued Liabilities Current	45	38	50	37	32	27	37	51	39	38	53	34
Operating Lease Liability Current	0	0	1	2	4	6	6	5	5	5	5	5
Long Term Debt Current	0	11	23	34	34	45	45	45	45	45	34	23
Other Liabilities Current	0	0	0	0	0	0	0	-	-	-	-	-
Liabilities Current	50	60	81	83	79	87	96	110	104	98	99	67
Operating Lease Liability Noncurrent	4	5	5	5	0	0	1	3	4	6	7	8
Liabilities	54	64	86	88	90	99	121	150	156	163	177	165
Stockholders Equity
Long Term Debt Noncurrent	-	0	0	0	11	11	22	33	44	55	66	77
Other Liabilities Noncurrent	-	-	0	0	0	0	0	0	0	-	0	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,418	1,416	1,414	1,412	1,411	1,409	1,407	1,405	1,403	1,401	1,399	1,396
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	-0	-0	0	0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-1,279	-1,288	-1,284	-1,297	-1,306	-1,312	-1,315	-1,334	-1,355	-1,350	-1,345	-1,357
Stockholders Equity	139	128	130	115	105	97	92	71	49	51	53	39
Liabilities And Stockholders Equity	193	193	216	203	195	196	213	221	205	214	231	204
Allowance For Doubtful Accounts Receivable Current	-	-	0	0	0	1	0	1	1	1	1	1
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	51	51	50	50	50	50	49	49	48	48	48	48
Shares Outstanding	51	51	50	50	50	50	49	49	48	48	48	48

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-1.24%	11.71%	9.92%	-	-	-	-	-	-	-	-	-
2025	6.84%	8.47%	6.84%	53.19%	47.11%	58.97%	3.06%	25.71%	31.02%	-19.47%	-1.71%	-8.95%
2024	-19.35%	-39.72%	-26.21%	-27.43%	-25.71%	-17.71%	11.88%	1.65%	-2.31%	17.39%	-4.35%	13.38%
2023	-	-	-	-	-	-	74.30%	65.46%	89.16%	-14.31%	-19.45%	-34.08%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.91	2.38	2.00	1.74	1.73	1.53	1.54	1.42	1.32	1.46	1.57	1.86
Quick Ratio	2.57	2.18	1.89	1.57	1.57	1.37	1.38	1.37	1.20	1.34	1.46	1.72
Working Capital	95.25M	82.52M	81.43M	60.85M	57.48M	45.85M	51.55M	46.42M	33.42M	44.84M	56.80M	57.99M
Leverage & Debt
Debt to Equity	0.39	0.50	0.66	0.76	0.86	1.02	1.32	2.10	3.23	3.20	3.31	4.26
Interest Coverage TTM	8.65	5.70	5.63	4.13	4.73	3.31	2.49	2.46	1.41	1.94	2.45	2.10
Debt Ratio	0.28	0.33	0.40	0.43	0.46	0.51	0.57	0.68	0.76	0.76	0.77	0.81
Efficiency & Turnover
Asset Turnover TTM	1.19	1.17	1.06	1.00	1.19	1.13	1.04	1.15	1.08	1.10	1.04	1.14
Days Sales Outstanding TTM	47.33	41.37	68.46	75.94	41.41	39.02	63.23	62.65	49.46	44.89	68.30	45.40
Receivables Turnover TTM	7.71	8.82	5.33	4.81	8.81	9.35	5.77	5.83	7.38	8.13	5.34	8.04
Per Share Metrics
Diluted EPS TTM	0.51	0.48	0.61	0.73	0.97	0.76	0.62	0.47	0.18	0.32	0.45	0.08
Free Cash Flow Per Share TTM	0.81	1.05	0.83	0.85	0.89	0.63	0.80	0.69	0.69	0.74	0.30	0.24
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	74.83%	74.46%	74.53%	76.91%	72.33%	72.40%	72.06%	69.29%	73.08%	73.44%	73.40%	75.91%
Operating Profit Margin TTM	13.16%	12.98%	16.33%	15.83%	19.35%	16.01%	13.44%	13.30%	8.63%	11.46%	13.85%	12.16%
Net Profit Margin TTM	11.55%	10.73%	13.62%	17.44%	20.35%	16.36%	13.14%	9.54%	3.98%	6.78%	9.16%	1.62%
Growth Metrics
Net Revenue Growth (1Y)	-2.86%	-2.38%	-0.91%	-12.96%	8.63%	2.68%	-2.19%	6.30%	-4.77%	-3.59%	3.34%	5.25%
Net Income Growth (1Y)	-44.86%	-35.94%	2.75%	59.11%	455.63%	147.59%	40.23%	525.26%	-457.52%	219.91%	1,079,450.00%	-61.81%
EPS Growth (1Y)	-46.20%	-37.52%	-0.05%	54.90%	439.89%	140.57%	35.87%	506.28%	-446.17%	209.60%	1,023,110.82%	-63.38%
Valuation Metrics
P/E TTM	15.46	13.32	9.56	7.23	3.52	3.86	4.90	5.38	18.05	16.61	9.45	33.62
P/B TTM	2.98	2.53	2.28	2.32	1.63	1.51	1.61	1.76	3.25	5.01	3.82	3.23
P/S TTM	1.79	1.43	1.30	1.26	0.72	0.63	0.64	0.51	0.72	1.13	0.87	0.55
Market Cap	413.12M	324.90M	297.57M	267.30M	170.47M	146.80M	148.38M	124.97M	157.43M	255.40M	204.09M	124.98M
Enterprise Value	376.59M	299.99M	290.46M	247.49M	160.68M	139.75M	146.21M	135.78M	179.35M	278.67M	219.16M	142.48M
Calculated Values
Free Cash Flow TTM	41.09M	53.52M	41.66M	42.87M	44.22M	31.17M	38.86M	33.68M	33.25M	35.47M	14.37M	11.64M
Net Debt	-36.54M	-24.91M	-7.11M	-19.81M	-9.80M	-7.05M	-2.17M	10.81M	21.92M	23.27M	15.07M	17.50M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-12Sale

Owner: Stuglik, Brian M

Title: -

Shares: 8,100

Price/Share: $7.20

Value: $58,320.00

Shares Owned: 113,858

Relationship: Director

Ownership: Direct

2026-06-12Sale

Owner: Dorval, Allison

Title: -

Shares: 11,610

Price/Share: $7.20

Value: $83,592.00

Shares Owned: 90,780

Relationship: Director

Ownership: Direct

2026-06-12Sale

Owner: Wilson, Troy Edward

Title: -

Shares: 10,800

Price/Share: $7.20

Value: $77,760.00

Shares Owned: 59,750

Relationship: Director

Ownership: Direct

2026-06-12Sale

Owner: Moyes, Jay M

Title: -

Shares: 22,000

Price/Share: $7.22

Value: $158,840.00

Shares Owned: 58,322

Relationship: Director

Ownership: Direct

2026-06-12Sale

Owner: Senderowicz, Adrian

Title: -

Shares: 27,000

Price/Share: $7.20

Value: $194,400.00

Shares Owned: 27,000

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-12	Stuglik, Brian M	Director	-	Direct	Sale	8,100	7.20	$58,320.00	113,858	4
2026-06-12	Dorval, Allison	Director	-	Direct	Sale	11,610	7.20	$83,592.00	90,780	4
2026-06-12	Wilson, Troy Edward	Director	-	Direct	Sale	10,800	7.20	$77,760.00	59,750	4
2026-06-12	Moyes, Jay M	Director	-	Direct	Sale	22,000	7.22	$158,840.00	58,322	4
2026-06-12	Senderowicz, Adrian	Director	-	Direct	Sale	27,000	7.20	$194,400.00	27,000	4
2026-01-07	Nougues, Maximo F	Officer	Chief Financial Officer	Direct	Sale	6,405	5.88	$37,661.40	193,284	4
2026-01-07	Hunt, Douglas M	Officer	See Remarks	Direct	Sale	5,014	5.88	$29,482.32	155,907	4
2026-01-07	Auerbach, Alan H	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	18,012	5.88	$105,910.56	7,145,951	4
2025-11-11	Miller, Michael Patrick	Director	-	Direct	Sale	20,000	4.86	$97,200.00	54,000	4
2025-07-18	Cesano, Alessandra	Director	-	Direct	Sale	27,000	3.37	$90,990.00	41,850	4
2025-07-09	Hunt, Douglas M	Officer	See Remarks	Direct	Sale	3,443	3.54	$12,188.22	164,894	4
2025-07-09	Nougues, Maximo F	Officer	Chief Financial Officer	Direct	Sale	3,935	3.54	$13,929.90	204,229	4
2025-07-09	Auerbach, Alan H	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	21,580	3.54	$76,393.20	7,180,901	4
2025-06-13	Wilson, Troy Edward	Director	-	Direct	Sale	10,800	3.40	$36,720.00	43,550	4
2025-06-13	Dorval, Allison	Director	-	Direct	Sale	11,610	3.40	$39,474.00	75,390	4
2025-06-13	Stuglik, Brian M	Director	-	Direct	Sale	8,100	3.39	$27,459.00	94,958	4
2025-06-13	Cesano, Alessandra	Director	-	Direct	Sale	12,150	3.40	$41,310.00	68,850	4
2025-06-13	Senderowicz, Adrian	Director	-	Direct	Sale	27,000	3.40	$91,800.00	27,000	4
2025-06-13	Moyes, Jay M	Director	-	Direct	Sale	22,000	3.40	$74,800.00	53,322	4
2025-01-02	Auerbach, Alan H	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	33,841	3.15	$106,599.15	7,029,674	4
2025-01-02	Nougues, Maximo F	Officer	Chief Financial Officer	Direct	Sale	10,227	3.15	$32,215.05	152,295	4
2025-01-02	Ludwig, Jeffrey Jerome	Officer	Chief Commercial Officer	Direct	Sale	9,437	3.15	$29,726.55	108,951	4
2025-01-02	Hunt, Douglas M	Officer	See Remarks	Direct	Sale	8,633	3.15	$27,193.95	124,594	4
2024-08-12	Miller, Michael Patrick	Director	-	Direct	Sale	23,358	3.49	$81,519.42	47,000	4
2024-07-17	Nougues, Maximo F	Officer	Chief Financial Officer	Direct	Sale	4,156	3.70	$15,377.20	162,522	4
2024-07-17	Hunt, Douglas M	Officer	See Remarks	Direct	Sale	3,637	3.70	$13,456.90	133,227	4
2024-07-17	Auerbach, Alan H	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	21,920	3.70	$81,104.00	7,063,515	4
2024-07-17	Ludwig, Jeffrey Jerome	Officer	Chief Commercial Officer	Direct	Sale	2,598	3.70	$9,612.60	118,388	4
2024-07-02	Auerbach, Alan H	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	18,885	3.27	$61,753.95	7,085,435	4
2024-07-02	Hunt, Douglas M	Officer	See Remarks	Direct	Sale	4,349	3.27	$14,221.23	136,864	4
2024-07-02	Nougues, Maximo F	Officer	Chief Financial Officer	Direct	Sale	5,295	3.27	$17,314.65	166,678	4
2024-07-02	Ludwig, Jeffrey Jerome	Officer	Chief Commercial Officer	Direct	Sale	6,051	3.27	$19,786.77	120,986	4
2024-06-13	Moyes, Jay M	Director	-	Direct	Sale	22,000	3.34	$73,480.00	21,322	4
2024-06-13	Dorval, Allison	Director	-	Direct	Sale	11,000	3.37	$37,070.00	33,000	4
2024-06-13	Wilson, Troy Edward	Director	-	Direct	Sale	27,000	3.33	$89,910.00	350	4
2024-06-13	Senderowicz, Adrian	Director	-	Direct	Sale	27,000	3.33	$89,910.00	0	4
2024-06-13	Stuglik, Brian M	Director	-	Direct	Sale	9,900	3.39	$33,561.00	49,058	4
2024-01-03	Hunt, Douglas M	Officer	See Remarks	Direct	Sale	8,358	4.49	$37,527.42	103,319	4
2024-01-03	Ludwig, Jeffrey Jerome	Officer	Chief Commercial Officer	Direct	Sale	12,956	4.49	$58,172.44	99,970	4
2024-01-03	Auerbach, Alan H	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	41,396	4.49	$185,868.04	6,936,947	4
2024-01-03	Wong, Alvin F	Officer	Chief Scientific Officer	Direct	Sale	7,733	4.49	$34,721.17	98,214	4
2024-01-03	Nougues, Maximo F	Officer	Chief Financial Officer	Direct	Sale	15,682	4.49	$70,412.18	128,666	4
2023-12-04	Wong, Alvin F	Officer	Chief Scientific Officer	Direct	Sale	280	3.76	$1,052.80	97,934	4
2023-11-07	Miller, Michael Patrick	Director	-	Direct	Sale	25,000	2.83	$70,750.00	43,358	4
2023-07-03	Wong, Alvin F	Officer	Chief Scientific Officer	Direct	Sale	6,938	3.31	$22,964.78	105,947	4
2023-07-03	Nougues, Maximo F	Officer	Chief Financial Officer	Direct	Sale	14,680	3.31	$48,590.80	144,348	4
2023-07-03	Auerbach, Alan H	Director,Officer,TenPercentOwner	President and CEO	Direct	Sale	60,698	3.31	$200,910.38	6,978,343	4
2023-07-03	Ludwig, Jeffrey Jerome	Officer	Chief Commercial Officer	Direct	Sale	12,103	3.31	$40,060.93	112,926	4
2023-07-03	Hunt, Douglas M	Officer	See Remarks	Direct	Sale	7,809	3.31	$25,847.79	111,677	4
2023-06-13	Miller, Michael Patrick	Director	-	Direct	Sale	13,500	3.45	$46,575.00	41,358	4
2023-06-13	Moyes, Jay M	Director	-	Direct	Sale	22,000	3.45	$75,900.00	16,322	4
2023-06-13	Senderowicz, Adrian	Director	-	Direct	Sale	27,000	3.45	$93,150.00	0	4
2023-06-13	Dorval, Allison	Director	-	Direct	Sale	10,000	3.45	$34,500.00	17,000	4
2023-06-13	Wilson, Troy Edward	Director	-	Direct	Sale	27,000	3.45	$93,150.00	350	4
2023-06-13	Stuglik, Brian M	Director	-	Direct	Sale	9,900	3.46	$34,254.00	31,958	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

67.55%

Inst. Shares: 34,348,203

Shares Outstanding: 50,845,130

2025-12-31

65.60%

Inst. Shares: 32,806,674

Shares Outstanding: 50,011,485

2025-09-30

62.97%

Inst. Shares: 31,698,970

Shares Outstanding: 50,339,456

2025-06-30

60.55%

Inst. Shares: 30,091,775

Shares Outstanding: 49,700,217

2025-03-31

56.60%

Inst. Shares: 28,071,103

Shares Outstanding: 49,595,697

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	34,348,203	50,845,130	67.55%
2025-12-31	32,806,674	50,011,485	65.60%
2025-09-30	31,698,970	50,339,456	62.97%
2025-06-30	30,091,775	49,700,217	60.55%
2025-03-31	28,071,103	49,595,697	56.60%
2024-12-31	25,444,321	48,648,701	52.30%
2024-09-30	27,516,008	49,008,464	56.15%
2024-06-30	28,516,501	48,292,414	59.05%
2024-03-31	23,584,806	48,189,256	48.94%
2023-12-31	19,782,606	47,134,331	41.97%
2023-09-30	17,482,269	47,520,338	36.79%
2023-06-30	18,374,866	46,759,062	39.30%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

PUMA BIOTECHNOLOGY, INC. (PBYI) — SEC Financial Statements & Analysis

PUMA BIOTECHNOLOGY, INC. (PBYI) is a pharmaceutical preparations company, incorporated in DE. PUMA BIOTECHNOLOGY, INC. trades on Nasdaq as: PBYI. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), PUMA BIOTECHNOLOGY, INC. reported a -2.86% year-over-year revenue growth, a Gross Profit Margin of 74.83% (TTM), a Debt-to-Equity ratio of 0.39x, a Price-to-Sales (P/S) ratio of 1.79x (TTM), a Price-to-Book (P/B) ratio of 2.98x (TTM), at a market cap of $413.12M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -2.86%
Gross Profit Margin TTM: 74.83%
Debt To Equity: 0.39x
P/S TTM: 1.79x
P/B TTM: 2.98x
Market Cap: $413.12M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is PUMA BIOTECHNOLOGY, INC. in?

PUMA BIOTECHNOLOGY, INC. (PBYI) operates in the Pharmaceutical Preparations industry.

What is PBYI's market cap?

PUMA BIOTECHNOLOGY, INC. (PBYI) has a market capitalization of $413.12M as of 2026-06-30.

What is PBYI's P/E ratio?

PUMA BIOTECHNOLOGY, INC. (PBYI)'s trailing twelve month P/E ratio is 15.46x as of 2026-06-30.

What exchange does PBYI trade on?

PUMA BIOTECHNOLOGY, INC. (PBYI) trades on the Nasdaq.

Where is PUMA BIOTECHNOLOGY, INC. incorporated?

PUMA BIOTECHNOLOGY, INC. is incorporated in DE.